OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
OCUL on Nasdaq
Shares outstanding
214,467,875
Price per share
$9.95
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
191,540,727
Total reported value
$2,325,014,047
% of total 13F portfolios
0.02%
Share change
+2,380,785
Value change
+$29,960,603
Number of holders
246
Price from insider filings
$9.95
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +22% $371,574,057 +$142,354,542 31,785,634 +62% FMR LLC 30 Sep 2025
SUMMER ROAD LLC 5.7% $131,657,773 12,134,357 SUMMER ROAD LLC 04 Dec 2025
Deep Track Capital, LP 5.1% +20% $132,787,440 +$23,640,000 11,234,132 +22% Deep Track Capital, LP 05 Feb 2026
BlackRock, Inc. 5.8% $118,890,012 10,170,232 BlackRock, Inc. 30 Sep 2025
Venrock Healthcare Capital Partners III, L.P. 3.2% -59% $81,120,329 -$71,516,295 6,862,972 -47% Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
Opaleye Management Inc. 2.8% $34,305,750 4,342,500 Opaleye Management Inc. 31 Dec 2024

As of 31 Dec 2025, 246 institutional investors reported holding 191,540,727 shares of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL). This represents 89% of the company’s total 214,467,875 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) together control 70% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 15% 31,785,605 -0% 0.02% $385,877,240
BlackRock, Inc. 7.3% 15,602,394 +48% 0% $189,413,062
VANGUARD GROUP INC 5.4% 11,575,193 +26% 0% $140,522,844
Summer Road LLC 5.2% 11,108,555 -12% 98% $134,857,858
Avoro Capital Advisors LLC 5% 10,777,777 +5.1% 1.3% $130,842,213
Deep Track Capital, LP 3.8% 8,070,414 -32% 2.2% $97,974,826
VR ADVISER, LLC 3.4% 7,315,547 -44% 4.4% $88,810,741
TCG Crossover Management, LLC 2.7% 5,740,231 -6.2% 2.3% $69,686,404
ADAGE CAPITAL PARTNERS GP, L.L.C. 2.2% 4,625,050 +16% 0.08% $56,148,107
GEODE CAPITAL MANAGEMENT, LLC 2% 4,356,547 +30% 0% $52,895,581
ALLIANCEBERNSTEIN L.P. 2% 4,341,951 +27% 0.02% $52,711,285
JANUS HENDERSON GROUP PLC 2% 4,229,202 +106% 0.02% $51,321,367
STATE STREET CORP 2% 4,196,330 +21% 0% $50,943,446
Logos Global Management LP 1.6% 3,500,000 +7.7% 2.8% $42,490,000
MILLENNIUM MANAGEMENT LLC 1.5% 3,207,881 -17% 0.03% $38,943,675
Paradigm Biocapital Advisors LP 1.4% 2,935,284 -16% 0.95% $35,634,348
Octagon Capital Advisors LP 1.2% 2,623,600 -0.02% 4% $31,850,504
DELTEC ASSET MANAGEMENT LLC 1.2% 2,487,934 -9.9% 5% $30,203,519
CITADEL ADVISORS LLC 1.2% 2,475,849 -57% 0.02% $30,056,807
Woodline Partners LP 0.78% 1,666,136 +0% 0.08% $20,226,891
Opaleye Management Inc. 0.74% 1,595,000 0% 2.6% $19,363,300
GOLDMAN SACHS GROUP INC 0.72% 1,547,523 +94% 0% $18,786,930
Saturn V Capital Management LP 0.7% 1,504,880 +31% 3.4% $18,269,243
NORTHERN TRUST CORP 0.68% 1,462,503 +24% 0% $17,754,786
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.68% 1,460,457 +30% 0% $17,729,948

Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 191,540,727 $2,325,014,047 +$29,960,603 $12.14 246
2025 Q3 188,183,085 $2,200,137,136 +$370,394,002 $11.69 214
2025 Q2 156,434,424 $1,451,692,801 +$187,013,442 $9.28 182
2025 Q1 137,366,906 $1,007,015,604 +$22,122,134 $7.33 195
2024 Q4 133,836,935 $1,142,923,387 -$55,464,898 $8.54 177
2024 Q3 139,959,663 $1,219,693,896 +$26,591,052 $8.70 167
2024 Q2 137,374,655 $939,612,942 +$86,876,988 $6.84 148
2024 Q1 123,359,441 $1,120,804,208 +$453,790,279 $9.10 145
2023 Q4 73,706,225 $328,758,787 +$150,569,150 $4.46 118
2023 Q3 40,429,130 $126,952,212 -$14,507,076 $3.14 112
2023 Q2 43,457,924 $224,194,712 +$15,406,633 $5.16 132
2023 Q1 40,293,660 $212,326,580 +$6,217,594 $5.27 124
2022 Q4 39,631,821 $111,363,550 -$11,852,132 $2.81 110
2022 Q3 42,784,711 $177,641,770 -$6,246,780 $4.15 126
2022 Q2 44,283,851 $178,116,533 +$2,778,803 $4.02 121
2022 Q1 43,481,638 $215,332,400 +$8,618,176 $4.95 127
2021 Q4 41,528,139 $289,118,916 -$36,286,646 $6.97 137
2021 Q3 44,501,826 $445,218,082 -$45,732,043 $10.00 137
2021 Q2 48,348,304 $685,490,035 +$13,999,445 $14.18 146
2021 Q1 47,154,599 $773,686,821 -$65,718,337 $16.41 149
2020 Q4 50,434,472 $1,043,919,487 +$206,608,703 $20.70 146
2020 Q3 39,773,072 $302,720,116 +$7,274,447 $7.61 101
2020 Q2 38,676,765 $322,007,676 +$85,260,671 $8.33 103
2020 Q1 28,477,673 $140,961,353 +$17,928,044 $4.95 87
2019 Q4 25,199,716 $99,537,589 +$4,791,546 $3.95 77
2019 Q3 23,281,316 $70,779,921 +$1,143,980 $3.04 73
2019 Q2 22,700,375 $99,883,931 +$3,092,692 $4.40 66
2019 Q1 22,319,507 $88,607,906 +$2,352,091 $3.97 65
2018 Q4 21,483,102 $85,497,322 -$3,739,436 $3.98 66
2018 Q3 21,648,697 $148,941,295 -$1,204,780 $6.88 72
2018 Q2 22,017,576 $148,575,866 +$9,801,776 $6.75 69
2018 Q1 20,434,189 $133,026,813 +$45,596,053 $6.51 63
2017 Q4 13,505,162 $60,113,388 -$11,835,912 $4.45 67
2017 Q3 15,581,267 $96,508,272 -$1,101,751 $6.18 71
2017 Q2 15,456,517 $143,279,882 -$26,251,504 $9.27 71
2017 Q1 18,346,444 $170,228,516 +$20,289,375 $9.28 73
2016 Q4 17,394,280 $145,604,494 -$10,234,332 $8.37 76
2016 Q3 18,785,162 $129,054,713 -$2,936,943 $6.87 70
2016 Q2 19,471,110 $96,376,641 -$30,443,305 $4.95 74
2016 Q1 20,860,674 $201,445,609 -$1,629,571 $9.66 64
2015 Q4 21,056,974 $197,303,107 -$18,088,390 $9.37 71
2015 Q3 20,040,765 $281,768,540 +$49,654,282 $14.06 66
2015 Q2 16,138,941 $339,403,403 +$93,805,035 $21.03 71
2015 Q1 10,685,998 $448,639,275 +$240,805,053 $41.98 56
2014 Q4 5,006,746 $117,752,025 +$9,256,090 $23.52 36
2014 Q3 4,629,882 $69,305,000 +$69,305,000 $14.97 33